ResMed Inc. Common Stock (NY:RMD)

Quality compounders are well-oiled machines. Their competitive advantages allow them to make profits consistently and reinvest them into projects that generate even more profits, creating a virtuous...

Topics Stocks

3 Quality Compounders to Consider Right Now

February 11, 2026

ResMed’s fourth quarter performance drew a positive market reaction, with management attributing the outperformance to strong global demand for its masks and devices, as well as continued growth in its...

The Top 5 Analyst Questions From ResMed’s Q4 Earnings Call

February 05, 2026

Medical device company ResMed (NYSE:RMD) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11% year on year to $1.42 billion. Its non-GAAP profit of $2.81 per share...

Topics Earnings Economy

ResMed Inc (NYSE:RMD) Beats Q2 Earnings Estimates on Strong Margin Expansion ↗

January 29, 2026

Via Chartmill

ResMed Inc (NYSE:RMD) Stands Out as a High-Quality Dividend Stock ↗

January 29, 2026

Via Chartmill

ResMed Inc. (NYSE:RMD) Embodies Quality Investing Principles ↗

January 16, 2026

Via Chartmill

RMD Q4 Deep Dive: Mask Innovation and Digital Health Expansion Drive Growth

January 30, 2026

ResMed (RMD) Q2 2026 Earnings Call Transcript

Topics Economy

ResMed (RMD) Q2 2026 Earnings Call Transcript ↗

January 29, 2026

Via The Motley Fool

Topics Artificial Intelligence Earnings

ResMed (NYSE:RMD) Exceeds Q4 CY2025 Expectations

January 29, 2026

Medical device company ResMed (NYSE:RMD) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 11% year on year to $1.42 billion. Its non-GAAP profit of $2.81 per share was 3.2% above...

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026

January 29, 2026

Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what you need to know.

ResMed (RMD) To Report Earnings Tomorrow: Here Is What To Expect

January 27, 2026

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

1 Safe-and-Steady Stock Worth Investigating and 2 We Find Risky

January 25, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers.

Reflecting On Patient Monitoring Stocks’ Q3 Earnings: ResMed (NYSE:RMD)

January 14, 2026

Beyond the ZZZs: Stanford’s SleepFM Turns a Single Night’s Rest into a Diagnostic Powerhouse

Topics Artificial Intelligence

January 14, 2026

In a landmark shift for preventative medicine, researchers at Stanford University have unveiled SleepFM, a pioneering multimodal AI foundation model capable of predicting over 130 different health...

Via TokenRing AI

Topics Artificial Intelligence

ResMed (RMD): Buy, Sell, or Hold Post Q3 Earnings?

January 13, 2026

Since July 2025, ResMed has been in a holding pattern, floating around $254.41. The stock also fell short of the S&P 500’s 11.3% gain during that period.

Topics Stocks

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

January 08, 2026

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,...

1 Cash-Heavy Stock to Consider Right Now and 2 We Avoid

December 28, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off

December 21, 2025

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

December 18, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and...

2 Healthcare Stocks on Our Watchlist and 1 We Brush Off

December 16, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Topics Stocks

Which S&P500 stocks are moving before the opening bell on Wednesday? ↗

December 10, 2025

Via Chartmill

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

December 08, 2025

Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapy

New York, NY – December 10, 2025 – The U.S. stock market is currently experiencing a robust rally, with major indices positioned tantalizingly close to their all-time highs. This bullish sentiment,...

US Stock Market Rides High: Fed Rate Cut Fuels Optimism as Indices Eye Record Peaks

December 10, 2025

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

ResMed Inc. (NYSE:RMD) Offers a High-Quality Dividend Backed by Strong Fundamentals ↗

December 08, 2025

ResMed (RMD) is a high-quality dividend stock with a secure payout, strong profitability, and a rock-solid balance sheet, ideal for sustainable passive income growth.

Via Chartmill

Q3 2025 Earnings Showcase Corporate Resilience Amidst AI Boom, But Future Growth Faces Scrutiny

December 09, 2025

The corporate earnings landscape as of December 9, 2025, presents a complex yet compelling narrative. While the third quarter of 2025 largely concluded with robust performance across the S&P 500,...

Via MarketMinute

Topics Artificial Intelligence Economy Government

These S&P500 stocks that are showing activity before the opening bell on Friday. ↗

December 05, 2025

Pre-market stock analysis of S&P500 stocks on 2025-12-05: top gainers and losers in today's session.

Via Chartmill

1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds

December 01, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut.

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

November 21, 2025

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

Topics Economy

1 Large-Cap Stock to Target This Week and 2 We Brush Off

November 19, 2025